Pfizer withdraws emergency use application for COVID-19 vaccine in India

pharmanewsdaily- February 5, 2021 0

US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series ... Read More

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

pharmanewsdaily- December 20, 2020 0

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company ... Read More

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 11, 2020 0

BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their ... Read More

Pfizer, BioNTech get Canadian approval for BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 9, 2020 0

US pharma giant Pfizer and German biotech company BioNTech have bagged Health Canada approval for their BNT162b2 Covid-19 vaccine. The BNT162b2 vaccine has been authorized ... Read More

UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 2, 2020 0

The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization ... Read More

BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech

pharmanewsdaily- November 10, 2020 0

Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in ... Read More

Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada

pharmanewsdaily- August 6, 2020 0

Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate against SARS-CoV2, depending on clinical success and ... Read More

BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

pharmanewsdaily- July 22, 2020 0

Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine ... Read More

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

pharmanewsdaily- July 14, 2020 0

Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More